Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01301378 · ClinicalTrials.gov registry record · NA

Patch Graft Material Safety and Effectiveness in Covering Glaucoma Drainage Device Tube

A NA study, sponsored by Wills Eye.

Terminated
Registry status
NA
Development phase
40
Enrollment target

NCT01301378: Clinical Trial NA study, sponsored by Wills Eye.

NCT01301378 is a NA study that was terminated before completion, run by Wills Eye. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01301378, a NA study, was terminated before completion, sponsored by Wills Eye.

TERMINATED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

The investigators hypothesize that KeraSys is a safe as Tutoplast to cover the tube of the Molteno 3 glaucoma drainage device during surgery

Primary Outcome

The patch graft will be graded on appearance at each visit by slit lamp for tube erosion and conjunctival retraction.

Interventions

  • PROCEDURE Molteno 3 glaucoma drainage shunt

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2010-08
Est. Completion 2011-01
Phase NA
Wills Eye

59 total trials

Why NCT01301378 stopped before completion

NCT01301378 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Molteno 3 glaucoma drainage shunt is the first listed.

NCT01301378 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01301378 about?

NCT01301378 is a clinical study titled "Patch Graft Material Safety and Effectiveness in Covering Glaucoma Drainage Device Tube". The investigators hypothesize that KeraSys is a safe as Tutoplast to cover the tube of the Molteno 3 glaucoma drainage device during surgery

What is the current status of trial NCT01301378?

This trial is currently terminated. It is a NA study. The enrollment target is 40 participants. The study started on 2010-08. Estimated completion is 2011-01.

What interventions are being tested in trial NCT01301378?

The interventions under investigation include: Molteno 3 glaucoma drainage shunt (PROCEDURE).

Who is sponsoring clinical trial NCT01301378?

This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01301378's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01301378, the US trial registry maintained by the National Library of Medicine. NCT01301378 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.